+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Alcohol Use Disorder Market by Treatment Type, Disorder Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967604
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Alcohol Use Disorder Market grew from USD 1.21 billion in 2023 to USD 1.28 billion in 2024. It is expected to continue growing at a CAGR of 6.50%, reaching USD 1.88 billion by 2030.

Alcohol Use Disorder (AUD) is a medical condition characterized by an inability to stop or control alcohol use despite adverse social, occupational, or health consequences. The global scope for AUD treatment encompasses a variety of interventions, including pharmacotherapy, behavioral therapies, and support groups, driven by a growing awareness and need for mental health resources. The necessity for addressing AUD is heightened by its substantial impact on public health, economic productivity, and quality of life, catalyzing a demand for effective treatment modalities and preventive measures. Treatment applications are diverse, ranging from detoxification programs to long-term rehabilitation, tailored to different levels of addiction severity. The primary end-users include rehabilitation centers, hospitals, and outpatient clinics, which are expanding their services to incorporate comprehensive treatment approaches. Key factors influencing growth in the AUD market include increasing alcohol consumption, rising incidences of alcohol-related disorders, and advancements in treatment technologies. Additionally, there is an uptick in government initiatives supporting mental health care and substance abuse treatment, further propelling market growth. However, challenges such as social stigma, limited access to treatment in certain regions, and high costs can hamper market expansion. Moreover, regulatory hurdles and the underreporting of cases pose additional barriers. A promising area for innovation lies in digital health solutions, such as telemedicine and mobile applications, offering personalized patient care and remote monitoring. Furthermore, research on new pharmaceuticals and holistic treatment methods can lead to breakthroughs in efficacious AUD management. To capitalize on these opportunities, stakeholders should invest in awareness campaigns, develop affordable solutions tailored to underserved markets, and foster collaborations with technology firms to enhance treatment accessibility and efficacy. These strategies could mitigate limitations while harnessing growth potential within this evolving healthcare niche.

Understanding Market Dynamics in the Alcohol Use Disorder Market

The Alcohol Use Disorder Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidences of substance abuse cases across the world
    • Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
    • Proliferation of digital and telehealth strategies for preventing and managing alcohol use
  • Market Restraints
    • Performance limitations and complexities in evaluating efficiency
  • Market Opportunities
    • Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
    • Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
  • Market Challenges
    • Complexities in developing alcohol use disorder therapeutics and diagnostics strategies

Exploring Porter’s Five Forces for the Alcohol Use Disorder Market

Porter’s Five Forces framework further strengthens the insights of the Alcohol Use Disorder Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Alcohol Use Disorder Market

External macro-environmental factors deeply influence the performance of the Alcohol Use Disorder Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Alcohol Use Disorder Market

The Alcohol Use Disorder Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Alcohol Use Disorder Market

The Alcohol Use Disorder Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Alcohol Use Disorder Market

The Alcohol Use Disorder Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alcohol Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Addex Therapeutics, Adial Pharmaceuticals, Alkermes, Astellas Pharma, Beckley Psytech Limited, BioCorRx, Inc., Bioprojet, Clairvoyant Therapeutics, Corcept Therapeutics Inc., GlaxoSmithKline PLC, Indivior Inc., Kinnov Therapeutics, Kinoxis Therapeutics, Lundbeck, MediciNova, Merck & Co. Inc., Omeros Corporation, Otsuka Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alcohol Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment Type
    • Behavioral Therapy
    • Detoxification
    • Inpatient Rehabilitation
    • Medication
  • Disorder Type
    • Alcohol Abuse
    • Alcohol Dependence
    • High-Functioning Alcoholism
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of substance abuse cases across the world
5.1.1.2. Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
5.1.1.3. Proliferation of digital and telehealth strategies for preventing and managing alcohol use
5.1.2. Restraints
5.1.2.1. Performance limitations and complexities in evaluating efficiency
5.1.3. Opportunities
5.1.3.1. Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
5.1.3.2. Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
5.1.4. Challenges
5.1.4.1. Complexities in developing alcohol use disorder therapeutics and diagnostics strategies
5.2. Market Segmentation Analysis
5.2.1. Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder
5.2.2. Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Alcohol Use Disorder Market, by Treatment Type
6.1. Introduction
6.2. Behavioral Therapy
6.3. Detoxification
6.4. Inpatient Rehabilitation
6.5. Medication
7. Alcohol Use Disorder Market, by Disorder Type
7.1. Introduction
7.2. Alcohol Abuse
7.3. Alcohol Dependence
7.4. High-Functioning Alcoholism
8. Alcohol Use Disorder Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies & Drug Stores
9. Americas Alcohol Use Disorder Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Alcohol Use Disorder Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Alcohol Use Disorder Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Researchers Receive USD 3.4 Million Grant to Study Alcohol Use Disorder Among People with Disabilities
12.3.2. Affect Raises USD 16 Million As Addiction-Related Financings Hold Strong
12.3.3. Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
FIGURE 2. ALCOHOL USE DISORDER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ALCOHOL USE DISORDER MARKET DYNAMICS
TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL ABUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HIGH-FUNCTIONING ALCOHOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Alcohol Use Disorder Market, which are profiled in this report, include:
  • Addex Therapeutics
  • Adial Pharmaceuticals
  • Alkermes
  • Astellas Pharma
  • Beckley Psytech Limited
  • BioCorRx, Inc.
  • Bioprojet
  • Clairvoyant Therapeutics
  • Corcept Therapeutics Inc.
  • GlaxoSmithKline PLC
  • Indivior Inc.
  • Kinnov Therapeutics
  • Kinoxis Therapeutics
  • Lundbeck
  • MediciNova
  • Merck & Co. Inc.
  • Omeros Corporation
  • Otsuka Pharmaceuticals
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information